Side Effects
KPV has demonstrated a favorable safety profile in preclinical studies. No acute toxicity has been reported in animal models at therapeutic doses, and the peptide does not appear to broadly suppress immune function in the way that corticosteroids or other immunosuppressive drugs do.
Commonly Reported (Anecdotal):
- Mild injection site reactions (redness, tenderness)
- Mild gastrointestinal discomfort (nausea, loose stools)
- Temporary skin redness or dryness with topical application
Less Commonly Reported:
- Allergic reactions to compound ingredients (redness, hives, stinging)
- Fatigue
- Headache
Safety Advantages: Unlike many anti-inflammatory medications, KPV does not appear to increase infection risk, cause tissue thinning, or produce the metabolic side effects associated with long-term corticosteroid use. Its targeted mechanism of NF-kB inhibition may provide anti-inflammatory benefits with a narrower side effect profile than broad-spectrum immunosuppressants.
Important Limitations: Long-term human safety data do not exist. KPV products from unregulated sources carry contamination risks, and batch-to-batch variability in purity and potency is a concern. Any use should be discussed with a qualified healthcare provider.